-- AlphaMena on Thursday lowered its price target for healthcare company Dallah Healthcare (SASE:4004) to 155 Saudi riyals from 160 riyals, while maintaining an add rating.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)